GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Aetna Inc (NYSE:AET) » Definitions » Forward PE Ratio

Aetna (AET) Forward PE Ratio : 0.00 (As of Apr. 26, 2024)


View and export this data going back to 1968. Start your Free Trial

What is Aetna Forward PE Ratio?

Aetna's Forward PE Ratio for today is 0.00.

Aetna's PE Ratio without NRI for today is 0.00.

Aetna's PE Ratio for today is 0.00.


Aetna Forward PE Ratio Historical Data

The historical data trend for Aetna's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aetna Forward PE Ratio Chart

Aetna Annual Data
Trend 2015-12 2016-12 2017-12 2018-11
Forward PE Ratio
13.28 14.14 17.92 16.75

Aetna Quarterly Data
2015-12 2016-03 2016-06 2016-09 2016-12 2017-03 2017-06 2017-09 2017-12 2018-03
Forward PE Ratio 13.28 13.04 14.60 13.09 14.14 14.62 17.12 15.85 17.92 16.05

Competitive Comparison of Aetna's Forward PE Ratio

For the Healthcare Plans subindustry, Aetna's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aetna's Forward PE Ratio Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Aetna's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Aetna's Forward PE Ratio falls into.



Aetna Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Aetna  (NYSE:AET) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Aetna Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Aetna's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aetna (AET) Business Description

Traded in Other Exchanges
N/A
Address
Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This large member count helps the firm diversify its operating risk and has formed the basis for material competitive advantages. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna and CVS recently announced their intention to merge operations, and if approved, it would form one of the most powerful players within the healthcare space.
Executives
Fernando Aguirre director CHIQUITA BRANDS INTERNATIONAL, 250 EAST FIFTH STREET, CINCINNATI OH 45202
Harold L Paz officer: EVP & Chief Medical Officer AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Molly Joel Coye director AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156
Jeffrey E Garten director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Frank M Clark director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Shawn M Guertin officer: Exec. Vice President, CFO TRINET GROUP, INC., ONE PARK PLACE, SUITE 600, DUBLIN CA 94568
Mark T Bertolini director, officer: Chairman and CEO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Karen S Lynch officer: President 151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156
Roger N Farah director POLO RALPH LAUREN CORP, 650 MADISON AVE, NEW YORK NY 10022
Ellen M Hancock director 126 LIMESTONE ROAD, RIDGEFIELD CT 06877
Edward J Ludwig director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Margaret M Mccarthy officer: EVP, Operations & Technology AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Olympia J. Snowe director 100 E. PRATT STREET, BALTIMORE MD 21202
Heather Brianne Dixon officer: VP, Controller & CAO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Sabatino Thomas J Jr officer: EVP & General Counsel C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015

Aetna (AET) Headlines

From GuruFocus

3 Strong ROC Stocks to Buy. Part 2

By Tiziano Frateschi Tiziano Frateschi 01-14-2015

Analysts Take Action on Health Care Stocks

By Alberto Abaterusso Alberto Abaterusso 01-23-2018

George Soros Exits Aetna, Microsoft

By Tiziano Frateschi Tiziano Frateschi 02-22-2019

Leucadia National Buys Aetna, Monsanto

By Tiziano Frateschi Tiziano Frateschi 03-12-2018

Here's a Stock-Market Tool That Isn't Used Much

By John Dorfman John Dorfman 07-20-2016

5 Health Care Stocks Gurus Are Buying

By Tiziano Frateschi Tiziano Frateschi 10-30-2018

The Eaton Vance Fund Exits Aetna, Bristol Myers

By Tiziano Frateschi Tiziano Frateschi 01-31-2019